Found 98 matching trials
Oral LBH589 in Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL) PHASE2 The purpose of the study is to find out the effects and the safety of an in...
Show More Location
H. Lee Moffitt Cancer Center and Research Institute
Learn More & Join Trial
Efficacy and Safety of LBH589 in Adult Patients With Refractory Chronic Myeloid Leukemia (CML) in Chronic Phase PHASE2 This study will evaluate the efficacy and safety of LBH589B in adult patien...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Safety Study of LBH589 When Given in Combination With Bortezomib in Adult Patients With Multiple Myeloma PHASE1 This study comprises of a dose-escalation and dose expansion phase and will...
Show More Location
Innovative Medical Research of South Florida Dept.ofInnovativeMedResearch
Learn More & Join Trial
Efficacy and Safety of LBH589B in Adult Patients With Refractory Chronic Myeloid Leukemia in Accelerated or Blast Phase PHASE2 This study will evaluate the efficacy and safety of LBH589B in adult patien...
Show More Location
City of Hope National Medical Center
Learn More & Join Trial
Panobinostat and Ruxolitinib in Primary Myelofibrosis, Post-polycythemia Vera-myelofibrosis or Post-essential Thrombocythemia-myelofibrosis PHASE1 This study will assess safety as well as establish a Recommended Phase II d...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Panobinostat (LBH589) and Imatinib Mesylate in Treating Patients With Previously Treated Chronic Phase Chronic Myelogenous Leukemia PHASE1 RATIONALE: Panobinostat and imatinib mesylate may stop the growth of cancer...
Show More Location
City of Hope Medical Center
Learn More & Join Trial
A Study to Investigate the Effects of Ketoconazole on LBH589 in Patients With Advanced Solid Tumors PHASE1 The primary purpose of this open-label study is to investigate the interact...
Show More Location
Nevada Cancer Institute
Learn More & Join Trial
Phase I Study of Panobinostat + Bortezomib for Relapsed and/or Refractory Mantle Cell Lymphoma (MCL) PHASE1 The purpose of this study is to determine the safety and clinical efficacy ...
Show More Location
Georgia Regents University
Learn More & Join Trial
A Phase III Randomized, Double Blind, Placebo Controlled Multi-center Study of Panobinostat for Maintenance of Response in Patients With Hodgkin's Lymphoma (HL) PHASE3 The primary objective was to provide drug to ongoing patients who were rece...
Show More Location
Cedars Sinai Medical Center
Learn More & Join Trial
A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma PHASE2 This phase II trial studies how well giving panobinostat together with lena...
Show More Location
Washington University
Learn More & Join Trial